Antithrombin Activity of Intact Human Platelets

Summary

Antithrombin activity has been identified in intact washed human platelets. An apparent activity was demonstrated at platelet concentrations above 0.31 × 10⁹/ml, when platelet suspensions were incubated with 2.0 NIH units/ml of thrombin. Neither red cells nor white cells revealed antithrombin activity. No significant loss of the platelet antithrombin activity was observed after ten successive washings or after treatment of platelets with antibodies to antithrombin III or α₂-macroglobulin. Almost the same amount of antithrombin activity as normal platelets was demonstrated in the platelets from an afibrinogenemic patient. Pre-treatment of platelets with trypsin, papain, and neuroaminidase reduced the activity significantly, whereas lipase was without effect. The platelet antithrombin reacted with thrombin in less than 3 seconds, and this rapid reaction of platelet antithrombin was different from that of plasma antithrombin III or fibrinogen. The thrombin-like clotting activity of ancrod was inhibited by fibrinogen but not platelets. Also, unlike plasma antithrombin III or fibrinogen, brief exposure to heat (56° C or 60° C) reduced considerable amounts of platelet antithrombin activity. These results suggest that platelets possess a specific antithrombin with different characteristics from other known antithrombins.

• References

• 1 Abildgaard U. 1968; Highly purified antithrombin III with heparin cofactor activity prepared by disc electrophoresis. Scandinavian Journal of Clinical and Laboratory Investigations 21: 89.
• 2 Aggeler P. M, Sahud M. A, and Robinson A. J. 1971. The role of platelets in blood coagulation. In: Brinkhous K. M, Shermer R. W, and Mostofi F. K. (eds.) The Platelet. The Williams & Wilkins; Baltimore, Maryland: 172.
• 3 Baenziger N. L, Brodie G. N, and Majerus P. W. 1972; Isolation and properties of a thrombin sensitive protein of human platelets. Journal of Biological Chemistry 247: 2723.
• 4 Chao F. C, Tullis J. L, Kenney D. M, Conneely F. S, and Doyle J. R. 1974; Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting. Thrombosis et Diathesis Haemorrhagica 32: 216.
• 5 Cohen I, Bohak Z, De Vries A, and Katchalsky E. 1969; Thrombosthenin M. Purification and interaction with thrombin. European Journal of Biochemistry 10: 388.
• 6 Detwiler T. C, and Feinman R. D. 1973; Kinetics of the thrombin-induced release of calcium (II) by platelets. Biochemistry 12: 282.
• 7 Doolittle R. F, Takagi T, and Cottrell B. A. 1974; Platelet and plasma fibrinogen are identical gene products. Science 185: 368.
• 8 Ganguly P. 1971; Isolation and properties of a thrombin sensitive protein from human blood platelets. Journal of Biological Chemistry 246: 4286.
• 9 Ganguly P. 1974; Binding of thrombin to human platelets. Nature 247: 306.
• 10 Glover G, and Shaw E. 1971; The purification of thrombin and isolation of a peptide containing the active center histidine. Journal of Biological Chemistry 246: 4594.
• 11 Grette K. 1962 Studies on the mechanism of thrombin-catalyzed hemostatic reactions in blood platelets. Acta Physiologica Scandinavia. 56: 195
• 12 Heimburger N, Haupt H, and Schwick H. G. 1971. Proteinase inhibitor of human plasma. In: Fritz H, and Tschesche H. (eds.) Proceedings of the International Research Conference on Proteinase Inhibitors, Munich, November, 1970. Walter de Gruyter; New York.: 1.
• 13 Hensen A, and Loeliger E. A. 1963 Antithrombin III. Its metabolism and its function in blood coagulation. Thrombosis et Diathesis Haemorrhagica. 9: Suppl. 1
• 14 Johnson S. A. 1971. Platelets in hemostasis and thrombosis. In: Johnson S. A. (ed.) The Circulating Platelet. Academic Press; New York.: 355.
• 15 Lanchantin G. F, Plesset M. L, Friedmann I. A, and Hart D. W. 1966; Dissociation of esterolytic and clotting activities of thrombin by trypsin-binding macroglobulin. Proceedings of the Society for Experimental Biology and Medicine 121: 444.
• 16 Loeliger A, and Hers J. F. P. 1957; Chronic antithrombinemia (antithrombin V) with hemorrhagic diathesis in a case of rheumatoid arthritis with hypergammaglobulin-aemia. Thrombosis et Diathesis Haemorrhagica 1: 499.
• 17 Monkhouse F. C, and Milojevic S. 1965; The inactivation of antithrombin by ether: Evidence against the existence of antithrombin IV. Canadian Journal of Physiology and Pharmacology 43: 819.
• 18 Nachman B. L, Marcus A. J, and Zucker-Franklin D. 1967; Immunological studies of proteins associated with subcellular fractions of normal human platelets. Journal of Laboratory and Clinical Medicine 69: 651.
• 19 Niewiarowski S, and Kowalski E. 1958; Un nouvel anticoagulant dérivé du fibrin-ogène. Revue Hématatologie 13: 320.
• 20 Phillips D. R, and Agin P. P. 1974; Thrombin substrates and the proteolytic site of thrombin action on human-platelet plasma membranes. Biochemica et Biophysica Acta 352: 218.
• 21 Rimon A, Shamash Y, and Shapiro B. 1966; The plasmin inhibitor of human plasma IV. Its action on plasmin, chymotrypsin and thrombin. Journal of Biological Chemistry 241: 5102.
• 22 Rosenberg R. D, and Damus P. S. 1973; The purification and mechanism of action of human antithrombin-heparin cofactor. Journal of Biological Chemistry 248: 6490.
• 23 Schwick H. G, Trobisch H, and Heimburger N. 1973; Leistungsfähigkeit und Grenzen immunologischer Methoden in der Gerinnungsdiagnostik. Internist 14: 160.
• 24 Seegers W. H, Johnson J. F, and Fell C. 1954; An antithrombin reaction related to prothrombin activation. American Journal of Physiology 176: 97.
• 25 Seegers W. H, Schröer H, and Kagami M. 1964; Inactivation of purified auto-prothrombin I with antithrombin. Canadian Journal of Biochemistry 42: 1425.
• 26 Solum N. D, and Lopaciuk S. 1969; Bovine platelet protein III. Some properties of platelet fibrinogen. Thrombosis et Diathesis Haemorrhagica 21: 428.
• 27 Steinbuch M, Biatriz C, and Jossa F. 1967; α₂-Macroglobulin as progressive antithrombin. Nature 216: 500.
• 28 Tollefsen D. M, Feagler J. R, and Majerus P. W. 1974; The binding of thrombin to the surface of human platelets. Journal of Biological Chemistry 249: 2646.
• 29 Tullis J. L, and Baudanza P. 1958. Methods for the study of human leukocytes, sedimentation techniques. In: Warren J. V. (ed.) Methods in Medical Research, vol. VII. The Year Book Publishers, Inc.; Chicago: 130.
• 30 Tullis J. L, Tinch R. J, Baudanza P, Gibson II J. C, Di Fortes S, Conneely G, and Murthy K. 1971; Plateletpheresis in a disposable system. Transfusion 11: 368.
• 31 Waugh D. F, Baughman D. J, and Juvkam-Wold C. 1968; Properties of thrombin and fibrinogen, the composition of clotting time averages. Thrombosis et Diathesis Haemorrhagica 20: 477.